Gene · 26227
Papers4,529
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,529
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Senescence-SASP Landscape in Colon Adenocarcinoma: Prognostic and Therapeutic Implications. | Curr Issues Mol Biol | 2026 | 41614944 | PubTator, text mining | PubMed |
| Exploring the relationship between metabolism and immune microenvironment in breast cancer bone metastasis based on metabolic pathways. | PLoS One | 2026 | 41610108 | PubTator, text mining | PubMed |
| XPR1 downregulation inhibits hepatocellular carcinoma progression by suppressing serine metabolism. | Redox Biol | 2026 | 41592436 | PubTator, text mining | PubMed |
| Exploring the key molecular mechanisms and immune microenvironment of oxidative stress-related pathways in pancreatic neuroendocrine tumor combining scRNA-seq and bulk RNA. | Discov Oncol | 2026 | 41591671 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
| Exploring molecular signatures in PURA syndrome using muscle proteomics and serum biomarkers. | J Neurol | 2026 | 41575592 | PubTator, text mining | PubMed |
| tRF-Gly-CCC-012 enhances malignant process in pancreatic cancer via the HNRNPC/PHGDH axis. | Biochem Pharmacol | 2026 | 41571199 | PubTator, text mining | PubMed |
| Exploring phenotype-related single-cells through attention-enhanced representation learning. | Genome Med | 2026 | 41566378 | PubTator, text mining | PubMed |
| Structural Dynamics of Peptiplexes Formed between Cationic Cell-Penetrating Peptides and DNA: A Comparative Study on TAT-HIV and NLS-SV40T. | ACS Appl Bio Mater | 2026 | 41557508 | PubTator, text mining | PubMed |
| The role of histone demethylase PHF2 as a tumour suppressor in hepatocellular carcinoma by regulating SRXN1. | Oncogenesis | 2026 | 41554700 | PubTator, text mining | PubMed |
| Live Metabolomics with NMR. | Anal Chem | 2026 | 41553924 | PubTator, text mining | PubMed |
| Identification of prognostic signatures in pheochromocytomas and paragangliomas based on mitochondrial autophagy and ferroptosis in TCGA and GEO datasets. | Discov Oncol | 2026 | 41543804 | PubTator, text mining | PubMed |
| Risk Factors and Outcomes of Reintubation Following Combined Heart-Lung Transplantation. | Clin Transplant | 2026 | 41532303 | PubTator, text mining | PubMed |
| Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer. | Cancer Cell | 2026 | 41512870 | PubTator, text mining | PubMed |
| Mechanisms of cellular senescence combined with molecular docking strategies: A biomarker study of potential therapeutic targets for allergic rhinitis. | PLoS One | 2026 | 41511918 | PubTator, text mining | PubMed |
| Understanding and Managing Infantile PHGDH Deficiency: A Case Report. | Neurol India | 2026 | 41510869 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Reveals Novel Molecular Mechanisms and Therapeutic Targets in Acute Myeloid Leukaemia. | J Cell Mol Med | 2026 | 41492215 | PubTator, text mining | PubMed |
| PHGDH at the crossroads: metabolic plasticity, metastatic paradoxes, and therapeutic reconnaissance in cancer. | J Biomed Sci | 2026 | 41486146 | PubTator, text mining | PubMed |
| AI-assisted protein design to rapidly convert antibody sequences to intrabodies targeting diverse peptides and histone modifications. | Sci Adv | 2026 | 41481731 | PubTator, text mining | PubMed |
| PHGDH as a therapeutic node: Natural modulators from TCM, degradation pathways, and emerging TPD strategies. | Pharmacol Res | 2026 | 41448556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26227/papers?page=8